A large retrospective analysis of the activity of pemetrexed (PEM) in patients (pts) with ALK-positive (ALK plus ) non-small cell lung cancer (NSCLC) prior to crizotinib (CRIZ) Meeting Abstract


Authors: Scagliotti, G.; Kim, D. W.; Shaw, A. T.; Ou, S. H. I.; Riely, G. J.; Gettinger, S. N.; Besse, B.; Thomas, M.; Salgia, R.; Wilner, K. D.; Bartlett, C. H.; Polli, A.; Gandara, D. R.
Abstract Title: A large retrospective analysis of the activity of pemetrexed (PEM) in patients (pts) with ALK-positive (ALK plus ) non-small cell lung cancer (NSCLC) prior to crizotinib (CRIZ)
Meeting Title: 48th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 30
Issue: 15 Suppl.
Meeting Dates: 2012 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2012-05-20
Language: English
ACCESSION: WOS:000318009804388
PROVIDER: wos
DOI: 10.1200/jco.2012.30.15_suppl.7599
Notes: Meeting Abstract: 7599 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gregory J Riely
    599 Riely